Uroalerts Men's Health Weekly

April 14, 2026

Videos

Peer-to-Peer Clinical Conversations

When to Consider Advanced Testing for Men with Lower Urinary Tract Symptoms - Hashim Hashim

Hashim Hashim

Hashim Hashim reviews video urodynamics indications for male lower urinary tract symptoms.

The UPSTREAM Trial on Urodynamics in Men with LUTS - Marcus Drake

Marcus Drake

Marcus Drake reviews the UPSTREAM trial showing urodynamics does not improve outcomes or reduce surgery rates on a population basis for men with lower urinary tract symptoms.

Beyond the Abstracts

Efficacy and Safety of Immune Checkpoint Blockade in Locally Advanced or Metastatic Penile Cancer: A Systematic Review and Meta-Analysis - Beyond the Abstract

New Insights into Nectin-4 Expression in Testicular Choriocarcinoma and Its Potential Treatment with Enfortumab Vedotin: Analysis of a Multi-Institutional Series and Association with Clinical-Pathological Features - Beyond the Abstract

Articles

Editor Selected Abstracts and Commentaries

Male Infertility

Association of blood biomarkers with p53 gene expression in male infertility.

Molecular and hormonal mechanisms of male infertility and their clinical implications.

Artificial Intelligence in Non-Obstructive Azoospermia: State of the Art in Sperm Retrieval.

Influence of Male Body Mass Index on Sperm Quality and In Vitro Fertilization Success Rates.

Peyronie's Disease

Extended corporal dilation decreases the need for intraoperative adjuvant maneuvers for residual curvature after inflatable penile implant placement in men with Peyronie's disease.

Erectile Dysfunction

Deep learning on genome-wide association studies to predict the patient-specific risk of radiation-induced erectile dysfunction.

Oral suspension versus tablet sildenafil for erectile dysfunction: a prospective multicenter comparative study on patient satisfaction.

Genetic biomarkers associated with risk and therapeutic response in erectile dysfunction: a systematic review.

Low-intensity shockwave therapy and pelvic floor muscle training each mitigate erectile dysfunction in men with diabetes: a randomised controlled trial.

Imaging review of male genitourinary devices and augmentations.

Efficacy and Safety of TESTOPEAK™ in Improving Symptoms of Andropause in Korean Men: An 8-Week, Single-Center, Randomized, Parallel-Group, Placebo-Controlled Trial.

BPH - Benign Prostatic Enlargement

Causal links of 233 metabolic markers to benign prostatic hyperplasia: Mendelian randomization and RNA- sequencing insights.

Safety and Efficacy of Holmium Laser Enucleation of the Prostate Within Two Weeks of Transrectal Ultrasound-Guided Prostate Biopsy.

Evaluation and management of transient lower urinary tract symptoms (LUTS) after surgery for Benign prostatic obstruction (BPO): a systematic review.

Transperineal 3D vector magnetic resonance elastography of the prostate is feasible in men with benign prostatic hyperplasia and lower urinary tract symptoms.

Endoscopic enucleation of the prostate made practical: lessons from experts from the BEAM25 meeting.

Decreasing Blood Loss in TURP Surgery: The Role of 5-Alpha Reductase Inhibitors: Enough To Make A Difference?

Penile & Urethral Cancers

Years of life lost in squamous cell carcinoma of the penis.

Prognostic value of the tumor immune microenvironment, PD-L1 and p16INK4A in penile squamous cell carcinoma.

Neoadjuvant and/or adjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced resectable penile squamous cell carcinoma.

Danish National Penile Cancer Database, DaPeCa-data: characteristics, management, and survival 2000-2025.

Testicular Cancer

Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden: insights from SWENOTECA.

Testicular Cancer: Diagnosis, Treatment, and Biomarker Advances.

Mental Health Burden of a Testicular Cancer Diagnosis: Insights from a Large Claims Database - Beyond the Abstract

Overlapping genetic etiology of pediatric and adult germ cell tumors.

Prostate Cancer

Pain and health-related quality-of-life outcomes with darolutamide in metastatic hormone-sensitive prostate cancer (ARANOTE): secondary and exploratory analyses of a multicentre, randomised, placebo-controlled, phase 3 trial.

Development of a Prognostic Prediction Model for Clinically Significant Prostate Cancer Based on Lesion Zone and Apparent Diffusion Coefficient Value Quantification - Beyond the Abstract

Efficacy and safety of darolutamide in combination with androgen deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial.

Cost-effectiveness of an artificial intelligence predictive model for guiding androgen deprivation therapy in intermediate-risk prostate cancer.

OncoEducate: A Pilot Study of Generative AI to Enhance Patient-Clinician Communication in Genitourinary Cancer Care.

Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 Patients.

Integrating Genomic Prostate Score with Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores to Predict Biochemical Recurrence after Radical Prostatectomy.

Hypo fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer: A Phase II Comparative Study of PSA Kinetics, Dosimetric and Toxicity Outcomes.

Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancer.

Identifying preferences for prostate cancer screening among American Indian men (Project AIMEPCCo): Protocol for a discrete choice experiment.

Evaluating an AI-driven Triaging Workflow for MRI-based Clinically Significant Prostate Cancer Diagnosis: A Simulation Study.

Integrative molecular analyses of lineage identity and morphology in aggressive variant prostate cancer.

Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancer.

CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer.

Changing trends in androgen deprivation therapy prescribing for prostate cancer in England, 2015-2024.

The Proposed Introduction of a Prostate Cancer Screening Program in Germany: Procedure, Necessary Studies before Implementation, Benefits, and Risks.

Novel Theranostic Targets for Prostate Cancer Beyond Prostate-Specific Membrane Antigen.

Castration Resistance Accelerates Prostate Cancer Kinetics.

Genomic Prostate Score (GPS) as a Prognostic Biomarker in Patients With Localized Prostate Cancer Undergoing Focal Therapy.

Stereotactic Body Radiation Therapy (SBRT)-Induced 68Ga-PSMA PET Bone Flare.

Trends and Disparities in the Use of Next-Generation Sequencing in Patients With Cancer in the United States.

Advances in Androgen Deprivation Therapy-Sparing Strategies: Ongoing Studies in Metastatic Castration-Sensitive Prostate Cancer.

Characterization of Clinically Significant Prostate Cancer in the Peripheral Zone Using Rapid B1-Insensitive MR Fingerprinting.

Moderate hypofractionation: long-term toxicity results of prostate bed radiotherapy (FRAME-PROSTATE).

Leveraging Population-Level and Multipayer Claims Data to Estimate Changes in Prostate Cancer Screening at the Small-Area Level.

Mediation analysis of adherence to pelvic floor muscle training and weekly self-monitoring on urinary symptoms in men with localized prostate cancer: A secondary analysis of the Prostate Cancer-Patient Empowerment Program (PC-PEP) randomized controlled tr

Clinical Characteristics and Predictive Factors of Symptomatic Skeletal Events in Patients With Metastatic Castration-Sensitive Prostate Cancer Treated With Denosumab.

Dosimetric comparison of implantable rectal spacers for low-dose-rate prostate brachytherapy.

Cost-effectiveness of PSMA-PET imaging technology in diagnosing and staging of prostate cancer: a systematic review.

The molecular pathology of prostate cancer: an update for practising pathologists.

Optimizing ChatGPT: Applying prompt engineering to frequently asked questions in urologic oncology.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC